Taiwan FDA registration 54489ea80ca3468c3bbcd5eb229a9212
Inno-Lia infectious disease analysis software
TW: 因諾-立亞感染性疾病分析軟體
Taiwan·Risk Class 2·FUJIREBIO EUROPE N.V.·Registered Oct 29, 2020 – Oct 29, 2025CancelledRegistration details
- Analysis ID
- 54489ea80ca3468c3bbcd5eb229a9212
- Customs Code
- DHA05603369801
Company information
- Manufacturer
- FUJIREBIO EUROPE N.V.
- Manufacturer Country
- Belgium
- Authorized Representative
- Taiwan Fu Pharmaceutical Co., Ltd
Product details
- Intended Use
- This product is used as a set of interpretation support tools for the analysis of diagnostic reagents.
- Product Type (Level 1)
- C Immunology and microbiology
- Product Type (Level 2)
- C.9999 Miscellaneous
- Import Information
- Input;; QMS/QSD
Dates and status
- Registration Date
- Oct 29, 2020
- Expiry Date
- Oct 29, 2025
- Cancellation Date
- Oct 28, 2022
Cancellation information
- Status
- Logged out
- Reason
- 公司歇業
About this record
Access comprehensive regulatory information for Inno-Lia infectious disease analysis software in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 54489ea80ca3468c3bbcd5eb229a9212 and manufactured by FUJIREBIO EUROPE N.V.. The authorized representative in Taiwan is Taiwan Fu Pharmaceutical Co., Ltd.
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices